Faculty

Institution

Unit

Venue

George V. Thomas

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

School of Dentistry

Department of Pathology and Radiology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

NoneGeorge V. Thomas is currently serving as a Biostatistics Shared Resources faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

George V. Thomas

Oregon Health & Science University

You can click a keyword to filter the displayed items

urology oncology prostate cancer cancer research pharmacology cancer biology tumor biology neurology medicinal research genitourinary cancers cell biology clinical research cancer care cancer cells cancer treatment oncogenes cancer genomics molecular cancer therapeutic targets cancer immunotherapy prostatic disease cancer genetics pharmacotherapy cancer discovery anti-cancer agents cellular therapy enzyme inhibition tumor targeting proteomics surgical oncology cancer management renal cell carcinoma experimental medicine molecular cell biology cancer imaging tumor suppressors oncogenic agent signaling pathways endocrine-related cancers androgen receptor castration-resistant prostate cancer genome biology kidney research hematological malignancies hormonal receptor vascular biology medical mycology tumor heterogeneity clinical mycology enzalutamide resistance drug targeting epigenetic changes cell regulation lineage plasticity malignant disease apoptosis clinical radiation oncology immune checkpoint inhibitors benign prostatic hyperplasia metastatic prostate cancer genomic characterization mouse models androgen receptor activity advanced prostate cancer serial biopsies intermediate atypical carcinoma drug targets endocrine oncology hypoxia (medicine) cell physiology cellular immune responses prostate-specific deletion enhanced sensitivity pten-deficient tumors multi-institutional prospective study cell surface

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors. Journal of Kidney Cancer and VHL (2025)

pathologyurologykidney cancermolecular cancercancer cellscancer biologyoncogenesoncogenic agenttumor microenvironmenttreatment resistancecancer genomicsnonclear cell tumorstumor biologycell biologyclear cellmolecular diagnosticstherapeutic targets

Elevated Tumor-Associated Androgen Receptor Activity Correlates With Poor Immune Infiltration and Immunotherapy Response Across Cancer Types. Cancer Research Communications (2025)

cancer immunotherapypathologypoor immune infiltrationtumor microenvironmentcancer lettercancer typesimmunotherapy responseimmunologyimmunotherapycancer immunosurveillancecancer cellsendocrine-related cancers

Genomic and Molecular Associations With Preoperative Immune Checkpoint Inhibition in Patients With Stage III Clear Cell Renal Cell Carcinoma. medRxiv (2025)

cancer immunotherapyurologykidney cancermolecular cancermolecular associationsgenitourinary cancerscancer genomicscancer discoveryimmunologyimmunotherapyimmune checkpoint inhibitorsjama oncology

MIROSCOPE: An AI-Driven Digital Pathology Platform for Annotating Functional Tissue Units. bioRxiv (Cold Spring Harbor Laboratory) (2025)

digital medicinebiological imagingbiomedical imagingmedical imagingsystems biologycomputer-aided diagnosisdigital pathologyfunctional tissue unitsbiomedical engineeringbiomedical analysisai healthcarebiomedical informatics

Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma. Metabolites (2025)

carcinogenesiscancer biologykidney cancermolecular cancercancer cellsmitochondrial functionmitochondrial translation inhibitioncell metabolismmolecular metabolismmolecular biologycritical metabolic–epigenetic interfacetumor biologyepigeneticscell biologymetabolic remodelingrenal cell carcinomametabolic pathways

Tmprss2 Expression in Lung Tissue of Prostatic Adenocarcinoma Patients: Androgen Deprivation Therapy and Relevance to Sars-Cov-2 Infection. Current Issues in Molecular Biology (2025)

pathologyurologylung tissuesars-cov-2tmprss2 expressionandrogen deprivation therapytherapeutic targetstumor biologyprostate cancerlung cancer

Tmprss2 Expression in Lung Tissue of Prostatic Adenocarcinoma Patients: A Pathologic Perspective on Androgen Deprivation Therapy. medRxiv (2025)

pathologyurologylung tissuetmprss2 expressionandrogen deprivation therapyoncologytherapeutic targetsprostatic diseasetumor biologyendocrine-related cancersprostate cancerlung cancer

Transcriptional Profiling Clarifies a Program of Enzalutamide Extreme Non-Response in Lethal Prostate Cancer. npj Precision Oncology (2025)

lethal prostate cancerpharmacologyurologymolecular cancertranscriptional profilingdrug discoveryenzalutamide extreme non-responsegenitourinary cancersoncologycancer genomicsprostatic diseasecancer cellsprostate cancer

Androgen Receptor Activity Inversely Correlates With Immune Cell Infiltration and Immunotherapy Response Across Multiple Cancer Lineages. bioRxiv (Cold Spring Harbor Laboratory) (2024)

cancer immunotherapycancer cellsoncogenesandrogen receptor activitytumor microenvironmentmultiple cancer lineageshormonal receptorimmunologyimmunotherapycancer immunosurveillancecell biologyendocrine-related cancersimmune cell infiltration

histiocytic transdifferentiationpathologyhistopathologyanatomical pathologylymphoid neoplasiamalignant diseasehematological malignanciesleukemiahistiocytic sarcomasarcomabenign cephalic histiocytosisadult t-cell leukemia-lymphomahematologypathologic lesions

1
2
3
4
5
12
10 / page

George V. Thomas

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

School of Dentistry

Department of Pathology and Radiology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

NoneGeorge V. Thomas is currently serving as a Biostatistics Shared Resources faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

George V. Thomas

Oregon Health & Science University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors. Journal of Kidney Cancer and VHL (2025)

Elevated Tumor-Associated Androgen Receptor Activity Correlates With Poor Immune Infiltration and Immunotherapy Response Across Cancer Types. Cancer Research Communications (2025)

Genomic and Molecular Associations With Preoperative Immune Checkpoint Inhibition in Patients With Stage III Clear Cell Renal Cell Carcinoma. medRxiv (2025)

cancer immunotherapyurologykidney cancermolecular cancermolecular associationsgenitourinary cancerscancer genomicscancer discoveryimmunologyimmunotherapyimmune checkpoint inhibitorsjama oncology

MIROSCOPE: An AI-Driven Digital Pathology Platform for Annotating Functional Tissue Units. bioRxiv (Cold Spring Harbor Laboratory) (2025)

Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma. Metabolites (2025)

Tmprss2 Expression in Lung Tissue of Prostatic Adenocarcinoma Patients: Androgen Deprivation Therapy and Relevance to Sars-Cov-2 Infection. Current Issues in Molecular Biology (2025)

pathologyurologylung tissuesars-cov-2tmprss2 expressionandrogen deprivation therapytherapeutic targetstumor biologyprostate cancerlung cancer

Tmprss2 Expression in Lung Tissue of Prostatic Adenocarcinoma Patients: A Pathologic Perspective on Androgen Deprivation Therapy. medRxiv (2025)

pathologyurologylung tissuetmprss2 expressionandrogen deprivation therapyoncologytherapeutic targetsprostatic diseasetumor biologyendocrine-related cancersprostate cancerlung cancer

Transcriptional Profiling Clarifies a Program of Enzalutamide Extreme Non-Response in Lethal Prostate Cancer. npj Precision Oncology (2025)

Androgen Receptor Activity Inversely Correlates With Immune Cell Infiltration and Immunotherapy Response Across Multiple Cancer Lineages. bioRxiv (Cold Spring Harbor Laboratory) (2024)

1
2
3
4
5
12
10 / page